HDFC Pharma and Healthcare Fund vs NJ Momentum Fund
Direct Plan, Growth option · Data as on 30-10-2026
HDFC Pharma and Healthcare Fund is a Thematic fund and NJ Momentum Fund is a Thematic fund. HDFC Pharma and Healthcare Fund charges 1.05% a year and NJ Momentum Fund 1.72% (Direct plans). Their portfolios overlap 10.4%: they hold 4 of the same securities.
HDFC Pharma and Healthcare Fund
Thematic
- Expense ratio
- 1.05%
- NAV
- ₹21.95
Which is better, HDFC Pharma and Healthcare or NJ Momentum? Key differences
It depends on what you want from the fund. These are the differences in numbers, from the data on this page.
- HDFC Pharma and Healthcare costs less: 1.05% a year against 1.72% (Direct plans).
- HDFC Pharma and Healthcare fell less in its worst fall since 03-08-2026: −9.8% against −10.8%.
- Their portfolios overlap 10.4%: 4 of the same holdings.
Past returns do not promise future returns. This page is information, not investment advice.
Key facts
From each fund's scheme summary document and AMFI
| Fact | HDFC Pharma and Healthcare Fund | NJ Momentum Fund |
|---|---|---|
| Fund house | HDFC Mutual Fund | NJ Mutual Fund |
| Category | Thematic | Thematic |
| AUM | ₹3,501 Cr (30-09-2026) | Not available |
| NAV | ₹21.95 (Direct) | ₹9.60 (Direct) |
| Expense ratio (Direct) | 1.05% | 1.72% |
| Expense ratio (Regular) | 2.13% | 3.51% |
| Riskometer | Very High | Very High |
| Benchmark | BSE Healthcare TRI | Nifty 500 TRI |
| Launch date | 04-10-2023 | 30-07-2026 |
| Minimum investment | ₹100 | ₹500 |
| Lock in | None | None |
| Fund managers | Nikhil Mathur, Gopal Agrawal, Bhagyesh Kagalkar | Dhaval Patel, Viral Shah, Jaimin Ilavia |
| Exit load | In respect of each purchase/switch-in of units, an Exit load of 1% is payable if units are redeemed /switched-out within 30 days from the date of allotment. No Exit Load is payable if units are redeemed / switched out after 30 days from the date of allotment. | Nil |
HDFC Pharma and Healthcare vs NJ Momentum: Returns Comparison
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
| Fund | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|---|
| HDFC Pharma and Healthcare Fund (Direct) | +0.04% | +0.83% | +16.68% | +23.12% | +30.53% | -- | -- |
| NJ Momentum Fund (Direct) | −3.42% | -- | -- | -- | -- | -- | -- |
| Thematic average | −2.09% | -- | -- | -- | -- | -- | -- |
Category average: the average of the 235 Thematic funds, same plan type.
HDFC Pharma and Healthcare vs NJ Momentum: Year-wise Returns
| Year | HDFC Pharma and HealthcareHDFC Pharma and Healthcare | NJ MomentumNJ Momentum |
|---|---|---|
| 2026to date | +23.99% | -- |
| 2025 | +2.42% | -- |
| 2024 | +52.22% | -- |
HDFC Pharma and Healthcare vs NJ Momentum: Rolling Returns
Every holding period of both funds, against BSE Healthcare TRI, the benchmark of HDFC Pharma and Healthcare Fund
HDFC Pharma and Healthcare vs NJ Momentum: Risk and Drawdowns
How much each fund swings, and the worst fall over the same days
Risk and return
| Measure | HDFC Pharma and Healthcare Fund (Direct) | NJ Momentum Fund (Direct) |
|---|---|---|
| Return (CAGR) | +29.32% | −16.97% |
| Standard deviation | 13.98% | 16.11% |
| Sharpe ratio | 1.66 | -1.38 |
| Sortino ratio | 2.38 | -1.73 |
| Maximum drawdown | −14.9% (28-02-2025) | −10.8% (23-10-2026) |
| Beta | 0.95 | 1.16 |
| Alpha | +8.51% | +17.26% |
From daily NAVs, 04-10-2023 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
HDFC Pharma and Healthcare Fund (Direct)
NJ Momentum Fund (Direct)
BSE Healthcare TRI
| Fund | Worst fall | High before it | Bottom | Back at the high | Time to climb back | Below its high today |
|---|---|---|---|---|---|---|
| HDFC Pharma and Healthcare Fund (Direct) | −9.8% | 21-09-2026 | 23-10-2026 | Not yet | -- | −4.1% |
| NJ Momentum Fund (Direct) | −10.8% | 31-08-2026 | 23-10-2026 | Not yet | -- | −6.9% |
| BSE Healthcare TRI | −9.9% | 23-09-2026 | 23-10-2026 | Not yet | -- | −3.8% |
From daily values since 03-08-2026, the first day every fund has.
HDFC Pharma and Healthcare vs NJ Momentum: Portfolio Overlap
From each fund's latest monthly portfolio: HDFC Pharma and Healthcare Fund, September 2026; NJ Momentum Fund, September 2026
Holdings in common
- Overlap
- 10.4%
- Held by both
- 4
- Only in HDFC Pharma and Healthcare
- 34
- Only in NJ Momentum
- 36
| Security | % of HDFC Pharma and Healthcare | % of NJ Momentum |
|---|---|---|
| Torrent Pharmaceuticals Ltd. | 3.65% | 3.63% |
| Lupin Ltd. | 3.55% | 3.26% |
| Acutaas Chemicals Limited | 3.18% | 2.56% |
| Zydus Lifesciences Limited | 1.82% | 1.00% |
Overlap: for each holding both funds own, the smaller of its two weights, added up. 10.4% means 10.4% of each fund's money sits in positions the other also holds. Matched by ISIN. Cash and hedged positions are left out.
Largest holdings only in HDFC Pharma and Healthcare Fund
| Security | % of fund |
|---|---|
| Divis Laboratories Ltd. | 9.39% |
| Sun Pharmaceutical Industries Ltd. | 8.28% |
| Alkem Laboratories Ltd. | 4.64% |
| Cipla Ltd. | 4.15% |
| Apollo Hospitals Enterprise Ltd. | 3.69% |
Largest holdings only in NJ Momentum Fund
| Security | % of fund |
|---|---|
| Welspun Corp Limited | 6.72% |
| Multi Commodity Exchange of India Limited | 4.68% |
| Kirloskar Oil Engines Limited | 4.30% |
| Laurus Labs Limited | 4.22% |
| Titan Company Limited | 3.84% |
Asset and sector split
Share of each fund, from its latest monthly portfolio
Asset allocation
| Asset | HDFC Pharma and Healthcare | NJ Momentum |
|---|---|---|
| Equity | 96.8% | 99.7% |
| Debt | 0.0% | 0.0% |
| Cash and others | 3.2% | 0.3% |
Market cap of stocks
| Market cap | HDFC Pharma and Healthcare | NJ Momentum |
|---|---|---|
| Large Cap | 29.2% | 28.0% |
| Mid Cap | 30.1% | 37.8% |
| Small Cap | 32.5% | 33.9% |
| Not on AMFI's list | 5.0% | 0.0% |
Share of the whole fund. Groups follow AMFI's latest list: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Largest sectors
| Sector | HDFC Pharma and Healthcare | NJ Momentum |
|---|---|---|
| Pharmaceuticals & Biotechnology | 71.3% | 19.7% |
| Healthcare Services | 22.1% | 0.0% |
| Industrial Products | 0.0% | 15.7% |
| Banks | 0.0% | 13.1% |
| Auto Components | 0.0% | 10.0% |
| Finance | 0.0% | 6.4% |
| Chemicals & Petrochemicals | 0.0% | 6.2% |
| Healthcare Equipment & Supplies | 2.4% | 0.0% |
| Retailing | 1.0% | 0.0% |
The six largest sectors of each fund's stocks, % of the fund.
HDFC Pharma and Healthcare vs NJ Momentum: Expense Ratio
What each plan charges a year, from AMFI's expense ratio file
| Charge | HDFC Pharma and Healthcare Fund | NJ Momentum Fund |
|---|---|---|
| Total expense ratio (Direct) | 1.05% | 1.72% |
| Base expense ratio (Direct) | 0.71% | 0.58% |
| Total expense ratio (Regular) | 2.13% | 3.51% |
| Base expense ratio (Regular) | 1.65% | 2.10% |
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, transaction costs, and levies with GST.
More comparisons
Each fund against the others of its category
Compare HDFC Pharma and Healthcare with
HDFC Pharma and Healthcare Fund vs NJ Momentum Fund: Frequently Asked Questions
What is the difference between HDFC Pharma and Healthcare Fund and NJ Momentum Fund?
HDFC Pharma and Healthcare Fund is a Thematic fund, NJ Momentum Fund is a Thematic fund, run by HDFC Mutual Fund and NJ Mutual Fund. Their portfolios overlap 10.4%. HDFC Pharma and Healthcare Fund charges 1.05% a year and NJ Momentum Fund 1.72%.
Which has the lower expense ratio, HDFC Pharma and Healthcare Fund or NJ Momentum Fund?
HDFC Pharma and Healthcare Fund charges less: 1.05% a year against 1.72%. These are the Direct plans' total expense ratios reported to AMFI.
How much do HDFC Pharma and Healthcare Fund and NJ Momentum Fund overlap?
10.4%. They hold 4 of the same securities, the largest shared ones being TORNTPHARM, LUPIN, ACUTAAS. From each fund's latest monthly portfolio.
Which is riskier, HDFC Pharma and Healthcare Fund or NJ Momentum Fund?
On SEBI's riskometer, HDFC Pharma and Healthcare Fund is rated Very High and NJ Momentum Fund Very High. Over their common history, the standard deviation of daily returns was 13.98% and 16.11% a year.
Can I invest in both HDFC Pharma and Healthcare Fund and NJ Momentum Fund?
Yes. 10.4% of each fund's money sits in the same holdings, so some of the two investments would move together.
Who manages HDFC Pharma and Healthcare Fund and NJ Momentum Fund?
HDFC Pharma and Healthcare Fund: Nikhil Mathur, Gopal Agrawal, Bhagyesh Kagalkar. NJ Momentum Fund: Dhaval Patel, Viral Shah, Jaimin Ilavia.
Sources: NAV and expense ratio from AMFI. Holdings from each fund house's monthly portfolio statement. Fund facts from each scheme summary document.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.